Suppr超能文献

肝硬化与心肌病的关联

Association of Cirrhosis and Cardiomyopathy.

作者信息

Sezgin Burcu, Cindoglu Cigdem, Uyanikoglu Ahmet, Yenice Necati

机构信息

Department of Internal Medicine, Sanliurfa Education Research Hospital, Sanliurfa, Turkey.

Department of Internal Medicine, Harran University, Sanliurfa, Turkey.

出版信息

Euroasian J Hepatogastroenterol. 2019 Jan-Jun;9(1):23-26. doi: 10.5005/jp-journals-10018-1291.

Abstract

INTRODUCTION

We investigated association of pro-BNP, troponin-I, electrocardiography (ECG) and echocardiography (ECHO) during diagnosis and identification of cirrhotic cardiomyopathy in cirrhotic patients.

MATERIALS AND METHODS

Patients were divided into three groups as; compensated cirrhotic patients (group 1, n= 30), decompensated cirrhotic (group 2, n = 30) and control group (group 3, n = 30). ECHO, and ECG were performed, and troponin-I and levels of pro-BNP were analyzed.

RESULTS

Average age of group 1 was 46.36 ± 16 years (range 19-86), 60% were female; group 2 was 57.03 ± 13.54 years (range 22-89), 56% female; and group 3 was 49.13 ± 0.95 years (range 18-80), 56% female. A significant increase in QTc was detected in compensated cirrhotic patients compared to the control group (p <0.05). Pro-BNP levels were significantly higher (p <0.05) in the compensated cirrhotic group compared to the control group. The levels of pro-BNP were also significantly higher in the decompensated cirrhotic group compared compensated cirrhosis group and control group (p <0.001).

CONCLUSION

The increase of pro-BNP levels with severity of the disease in cirrhotic patients and the prolongation of QTc interval supports an association between these factors with cardiomyopathy.

HOW TO CITE THIS ARTICLE

Sezgin B, Cindoglu C, et al. Association of Cirrhosis and Cardiomyopathy. Euroasian J Hepatogastroenterol 2019;9(1):23-26.

摘要

引言

我们研究了在肝硬化患者诊断和鉴别肝硬化性心肌病过程中,脑钠肽前体(pro-BNP)、肌钙蛋白I、心电图(ECG)和超声心动图(ECHO)之间的关联。

材料与方法

患者被分为三组,分别为:代偿期肝硬化患者(第1组,n = 30)、失代偿期肝硬化患者(第2组,n = 30)和对照组(第3组,n = 30)。进行了超声心动图和心电图检查,并分析了肌钙蛋白I和脑钠肽前体水平。

结果

第1组的平均年龄为46.36±16岁(范围19 - 86岁),女性占60%;第2组为57.03±13.54岁(范围22 - 89岁),女性占56%;第3组为49.13±0.95岁(范围18 - 80岁),女性占56%。与对照组相比,代偿期肝硬化患者的QTc显著延长(p <0.05)。与对照组相比,代偿期肝硬化组的脑钠肽前体水平显著更高(p <0.05)。与代偿期肝硬化组和对照组相比,失代偿期肝硬化组的脑钠肽前体水平也显著更高(p <0.001)。

结论

肝硬化患者中脑钠肽前体水平随疾病严重程度增加以及QTc间期延长,支持这些因素与心肌病之间存在关联。

如何引用本文

Sezgin B, Cindoglu C, 等。肝硬化与心肌病的关联。《欧亚肝脏胃肠病学杂志》2019;9(1):23 - 26。

相似文献

1
Association of Cirrhosis and Cardiomyopathy.
Euroasian J Hepatogastroenterol. 2019 Jan-Jun;9(1):23-26. doi: 10.5005/jp-journals-10018-1291.
3
Cirrhotic cardiomyopathy: Isn't stress evaluation always required for the diagnosis?
World J Hepatol. 2016 Jan 28;8(3):200-6. doi: 10.4254/wjh.v8.i3.200.
6
Effect of liver transplantation on QT-interval prolongation and impact on mortality.
Int J Cardiol. 2021 Mar 1;326:158-163. doi: 10.1016/j.ijcard.2020.11.017. Epub 2020 Nov 11.
7
Electrocardiographic Changes in Liver Cirrhosis-Clues for Cirrhotic Cardiomyopathy.
Medicina (Kaunas). 2020 Feb 10;56(2):68. doi: 10.3390/medicina56020068.
8
Relation of B-type natriuretic peptide level in heart failure to sudden cardiac death in patients with and without QT interval prolongation.
Am J Cardiol. 2013 Mar 15;111(6):886-90. doi: 10.1016/j.amjcard.2012.11.041. Epub 2012 Dec 28.
10
Protective role of cardiac-specific overexpression of caveolin-3 in cirrhotic cardiomyopathy.
Am J Physiol Gastrointest Liver Physiol. 2020 Mar 1;318(3):G531-G541. doi: 10.1152/ajpgi.00346.2019. Epub 2020 Jan 21.

引用本文的文献

1
Evaluating Diastolic Dysfunction as an Indicator of Cirrhotic Cardiomyopathy in Decompensated Chronic Liver Disease.
Cureus. 2024 Jun 28;16(6):e63388. doi: 10.7759/cureus.63388. eCollection 2024 Jun.
2
QTc prolongation in patients of cirrhosis and its relation with disease severity: An observational study from a rural teaching hospital.
J Family Med Prim Care. 2020 Jun 30;9(6):3020-3024. doi: 10.4103/jfmpc.jfmpc_341_20. eCollection 2020 Jun.

本文引用的文献

1
Defining acute-on-chronic liver failure: East, West or Middle ground?
World J Hepatol. 2015 Nov 8;7(25):2571-7. doi: 10.4254/wjh.v7.i25.2571.
3
Cardiac imaging in patients with chronic liver disease.
Clin Physiol Funct Imaging. 2017 Jul;37(4):347-356. doi: 10.1111/cpf.12311. Epub 2015 Nov 5.
5
Cirrhotic cardiomyopathy in the pre- and post-liver transplantation phase.
J Cardiol. 2016 Feb;67(2):125-30. doi: 10.1016/j.jjcc.2015.04.016. Epub 2015 Jun 11.
6
Complications of cirrhosis. A 50 years flashback.
Scand J Gastroenterol. 2015 Jun;50(6):763-80. doi: 10.3109/00365521.2015.1021709. Epub 2015 Apr 16.
7
QT Indexes in Cirrhotic Patients: Relationship with Clinical Variables and Potential Diagnostic Predictive Value.
Arch Med Res. 2015 Apr;46(3):207-13. doi: 10.1016/j.arcmed.2015.03.008. Epub 2015 Apr 2.
8
Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II).
Wien Klin Wochenschr. 2013 Apr;125(7-8):200-19. doi: 10.1007/s00508-013-0337-z. Epub 2013 Apr 12.
9
Cirrhotic cardiomyopathy.
J Hepatol. 2010 Jul;53(1):179-90. doi: 10.1016/j.jhep.2010.02.023. Epub 2010 Mar 31.
10
Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications.
Handb Exp Pharmacol. 2009(191):341-66. doi: 10.1007/978-3-540-68964-5_15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验